This award supports rapid implementation of clinical trials targeting autism treatment or management. Funded projects may evaluate new drugs, biologics, devices, clinical guidance, or emerging technologies, ranging from pilot to large-scale efficacy trials. Applications must address specific ARP areas of interest and include community collaborations with active involvement of autistic individuals or caregivers. Early-career investigators can partner with experienced PIs for enhanced funding.
Open to any type of entity, with no stated restrictions. Applications must include community collaborations and may partner experienced PIs with early-career investigators.
